Shaw Brian I, Villani Vincenzo, Kesseli Samuel J, Nobuhara Chloe, Samoylova Mariya L, Moris Dimitrios, Collins Bradley H, McElroy Lisa M, Poh Melissa, Knechtle Stuart J, Barbas Andrew S, Seigler Hilliard F
Department of Surgery, Duke University, Durham, NC 27710, USA.
School of Medicine, Duke University, Durham, NC 27710, USA.
J Clin Med. 2021 Nov 24;10(23):5505. doi: 10.3390/jcm10235505.
The impact of HLA matching on graft survival has been well characterized in renal transplantation, with a higher degree of matching associated with superior graft survival. Additionally, living donor grafts are known to confer superior survival compared to those from deceased donors. The purpose of this study is to report our multi-decade institutional experience and outcomes for patients who received HLA-identical living donor grafts, which represent the most favorable scenario in kidney transplantation. We conducted a retrospective analysis of these graft recipients performed at a Duke University Medical Center between the years of 1965 and 2002. The recipients demonstrated excellent graft and patient survival outcomes, superior to a contemporary cohort, with median patient and graft survival of 24.2 and 30.9 years, respectively, among Duke recipients vs. 16.1 and 16.0 years in a cohort derived from national data. This study offers a broad perspective on the importance of HLA matching and graft type, and demonstrates a historical best-case-scenario in renal transplantation.
HLA配型对肾移植中移植物存活的影响已得到充分阐明,配型程度越高,移植物存活情况越好。此外,已知活体供者的移植物相比 deceased 供者的移植物具有更好的存活率。本研究的目的是报告我们在数十年间对接受 HLA 相同活体供者移植物的患者的机构经验和结果,这代表了肾移植中最有利的情况。我们对1965年至2002年间在杜克大学医学中心进行的这些移植物受者进行了回顾性分析。受者表现出优异的移植物和患者存活结果,优于当代队列,杜克大学受者的患者和移植物中位存活时间分别为24.2年和30.9年,而来自国家数据的队列中这两个数字分别为16.1年和16.0年。本研究为 HLA 配型和移植物类型的重要性提供了广阔视角,并展示了肾移植中的一个历史最佳案例。